Enzon Pharmaceuticals, Inc. (ENZN)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.3 Million | -659 Thousand | -501 Thousand | -380 Thousand | 6.9 Million | -978 Thousand |
| Net Income | 1.37 Million | -186 Thousand | -469 Thousand | -1.31 Million | -979 Thousand | 5.84 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | -157 Thousand | -202 Thousand | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 89 Thousand | -271 Thousand | -32 Thousand | 931 Thousand | 7.88 Million | -6.82 Million |
| Other non-cash items | -157 Thousand | -28 Thousand | -29 Thousand | -948 Thousand | -6.88 Million | 6.78 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -1.27 Million | -1.27 Million | -2.02 Million | 43.07 Million | -7.95 Million | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -1.27 Million | -1.27 Million | -2.02 Million | -460 Thousand | -7.95 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 43.6 Million | - | - |
| Other Financing Activities | - | 1.27 Million | 2.02 Million | -64 Thousand | -7.95 Million | - |
| Accounts receivables | - | 28 Thousand | -23 Thousand | -28 Thousand | 7 Million | -7 Million |
| Accounts payables | - | - | 29 Thousand | -22 Thousand | -115 Thousand | 214 Thousand |
| Inventory | - | - | 23 Thousand | 28 Thousand | -7 Million | - |
| Other working capital | 89 Thousand | -299 Thousand | -61 Thousand | 953 Thousand | 7.99 Million | -7.04 Million |
| Cash at beginning of period | 46.98 Million | 47.64 Million | 48.14 Million | 5.44 Million | 6.5 Million | 7.47 Million |
| Cash at end of period | 47.01 Million | 46.98 Million | 47.64 Million | 48.14 Million | 5.44 Million | 6.5 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 30 Thousand | -659 Thousand | -501 Thousand | 42.69 Million | -1.05 Million | -978 Thousand |
| Free Cash Flow | 1.3 Million | -659 Thousand | -501 Thousand | -380 Thousand | 6.9 Million | -978 Thousand |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 254 Thousand | 276 Thousand | 320 Thousand | 672 Thousand | 1.37 Million | 321 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | 50 Thousand | 4000.00 | -1000.00 | -248 Thousand | -157 Thousand | 76 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 107 Thousand | -39 Thousand | -68 Thousand | 31 Thousand | 89 Thousand | 29 Thousand |
| Other non-cash items | -7000.00 | - | -1000.00 | -248 Thousand | -157 Thousand | 76 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | -1.27 Million | - | -1.27 Million | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | -1.27 Million | - | -1.27 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | -1.27 Million | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 107 Thousand | -39 Thousand | -68 Thousand | 31 Thousand | 89 Thousand | 29 Thousand |
| Cash at beginning of period | 46.22 Million | 45.98 Million | 47.01 Million | 46.55 Million | 46.98 Million | 46.13 Million |
| Cash at end of period | 46.63 Million | 46.22 Million | 45.98 Million | 47.01 Million | 47.01 Million | 46.55 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 404 Thousand | 241 Thousand | -1.02 Million | 455 Thousand | 30 Thousand | 426 Thousand |
| Free Cash Flow | 404 Thousand | 241 Thousand | 251 Thousand | 455 Thousand | 1.3 Million | 426 Thousand |
FZR
JRONF
IDEX
COLORCHIPS
BTR
600303